Health technology company Hundred Health today announced the official launch of its integrated health platform and mobile app, positioning itself at the forefront of preventive
TauC3 Biologics, a biotechnology company focused on developing therapies for neurodegenerative diseases, has secured approximately $2.5 million in new investor commitments, extending its operational runway
Chai Discovery, an AI-native drug discovery company, today announced it has raised $130 million in a Series B financing, valuing the company at $1.3 billion.
Cellular Origins, a Cambridge-based leader in manufacturing automation, today announced the successful closing of a $40 million over-subscribed Series A financing round, a major step
Eli Lilly and Company (NYSE: LLY) today announced that its experimental obesity therapy, retatrutide, demonstrated unprecedented efficacy in the Phase 3 TRIUMPH-4 trial, achieving an
“Suffering from Alzheimer’s means losing yourself bit by bit, but love and care can make this journey bearable.” – Unknown Hollywood has produced numerous films
Health technology company Hundred Health today announced the official launch of its integrated health platform and mobile app, positioning itself at the forefront of preventive
Serina Therapeutics, a leader in polymer-based drug development, today announced the appointment of Dr. Joshua Thomas as Vice President and Head of Chemistry. This strategic
ALZpath, Inc., a leading developer of innovative diagnostic tools for Alzheimer’s disease, today announced a licensing agreement with global medtech company Siemens Healthineers aimed at
California-based biotech Arrowhead Pharmaceuticals has emerged as one of 2025’s most remarkable turnaround stories, achieving a key milestone with the FDA approval of Redemplo (plozasiran)
